A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.97%
01/22/2025 01:58 PM - Society
Cold weather predicted for Lunar New Year
01/22/2025 01:46 PM - Politics
Taiwan urged to boost defense spending during Trump's second term
01/22/2025 12:12 PM - Society
Taiwan headline news
01/22/2025 10:39 AM - Business
Taiwan shares open higher
01/22/2025 10:01 AM